Compare TLX & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLX | LMND |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | Australia | United States |
| Employees | 1184 | 1282 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.0B |
| IPO Year | N/A | N/A |
| Metric | TLX | LMND |
|---|---|---|
| Price | $10.68 | $54.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $21.13 | ★ $70.86 |
| AVG Volume (30 Days) | 174.5K | ★ 1.7M |
| Earning Date | 08-19-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $65.20 |
| Revenue Next Year | N/A | $33.31 |
| P/E Ratio | $150.33 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.28 | $28.71 |
| 52 Week High | $18.13 | $99.90 |
| Indicator | TLX | LMND |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 39.91 |
| Support Level | $10.60 | $52.38 |
| Resistance Level | $11.18 | $59.42 |
| Average True Range (ATR) | 0.25 | 3.70 |
| MACD | -0.07 | -1.10 |
| Stochastic Oscillator | 49.19 | 15.09 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.